Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of dolastatin 10 in metastatic or recurrent liver cancer, extrahepatic bile duct cancer, and gallbladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Dolastatin 10 (dolastatin-10)

Snippet

Sponsor: University of Chicago | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED